More than Baby Steps for $IVOB
October 28th, 2009 at 6:29 am Posted by
Yesterday afternoon, $IVOB announced the results of their first 28 cycles of the INVO procedure performed at the CECOFLES fertility center in Columbia. The Dean believes these clinical results are BIG news for $IVOB because they prove that the INVO procedure has a 36% success rate, which is comparable to conventional IVF.
Less than three weeks ago, $IVOB announced the successful birth of the first baby conceived with their commercialized INVOcell device and INVO procedure. This news is also significant because the female patient was 40 years old and infertile for 16 years, prior to receiving $IVOB‘s treatment.
The Dean thinks there are other important items in these press releases that many have gone unnoticed but are meaningful for $IVOB in the long run. For example, the press release from October 9th tells the world that “hundreds of babies have been born from intra-vaginal culture utilizing the INVO prototype device” and yesterday’s release puts a number on it, 800.
So, the successful birth in Pakistan and announcement to come next week at the meeting of the Middle East Fertility Society could describe further success of the newer, commercialized INVOcell device which is distributed through Galaxy IVF in the Middle East.
Another significant bit of information consistent in both press releases is the age of the female patients who underwent the INVO procedure successfully. The most recent news describes that the average age of the patient was 34 years old, while the earlier news from Pakistan revealed that the patient was older—40 years old.
The Dean believes this is good news for $IVOB and their INVO procedure because many women in this age range could require multiple IVF cycles and numerous (more than 2) embryos transferred. But, the Pakistan pregnancy and birth involved a 40 year old woman and the transfer of a single embryo AND the INVO procedure uses the American Society for Reproductive Medicine’s (ASRM) recommended maximum of 2 embryos, if necessary. This reduces the likelihood of multiple-birth pregnancies and complications for mother-to-be and child.
The third thing that The Dean also noticed as a consistency between the press releases is the ease of use and comfort associated with the INVOcell device and INVO procedure. The report from Pakistan claims that “the mother could not believe how simple and natural the process was” and Dr. Elkin Lucina, of the CECOFLES fertility center, reported that “The procedure is easy to perform” and “the patients love being involved in the process.”
The Dean cannot believe how exciting the upcoming weeks and months could be for $IVOB because the INVO procedure and INVOcell device have proven to be effective, easy to use, more natural and less expensive than conventional methods of IVF.
